PF-07853578

N/A

Report date: 2024/06/21 16:38:44
NME

Base Information

Drug NamePF-07853578
Drug Alias NamePF-07853578
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 inhibitors
Targets1-acylglycerol-3-phosphate O-acyltransferase PNPLA3
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A